Cover Image
市場調查報告書

Nifuratel的中國市場

Investigation Report on China Nifuratel Market, 2010-2019

出版商 China Research and Intelligence 商品編碼 332298
出版日期 內容資訊 英文 30 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
Nifuratel的中國市場 Investigation Report on China Nifuratel Market, 2010-2019
出版日期: 2015年06月04日 內容資訊: 英文 30 Pages
簡介

Nifuratel自打入中國市場以來其銷售額急速擴大,2005年僅5萬3200人民幣的銷售額,到2014年已達3803萬人民幣的規模。此外,許多中國製藥企業也開始製造該藥的學名藥。

本報告提供中國的Nifuratel市場規模與今後預測,提供您主要製藥公司及劑型別市場佔有率,銷售價格等資訊。

第1章 Nifuratel的相關概念

  • 適應
  • 全球市場的銷售情形

第2章 中國Nifuratel的市場簡介

  • Nifuratel的專利及核準情況
  • 主要製藥公司
  • 市場規模

第3章 中國Nifuratel銷售情形調查

  • 銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 銷售量
    • 整體銷售量
    • 各地區的銷售數

第4章 中國Nifuratel的主要製藥公司市場佔有率調查

  • 以銷售額為準的市場佔有率
  • 以銷售量為準的市場佔有率

第5章 中國Nifuratel的劑型的相關調查

  • 劑型別市場佔有率:以銷售額為準
  • 劑型別市場佔有率:以銷售量為準

第6章 中國醫院的Nifuratel的標準價格

  • Monsanto Italy S.p.A. (Macmiror)
  • Beijing Laneva Pharmaceutical Co., Ltd (Lang Yi Jun)
  • Lifecare (Kuaihe) (Kuaihe)
  • Doppel Farmaceutici (Italy) (Macmiror)
  • Yantai Luyin Pharmaceutical Co., Ltd (Pu Le)

第7章 中國市場中Nifuratel的主要製藥公司

  • Lifecare
  • Beijing Laneva Pharmaceutical Co., Ltd
  • Yantai Luyin Pharmaceutical Co., Ltd
  • Doppel Farmaceutici (Italy)
  • Monsanto Italy S.p.A.

第8章 中國Nifuratel的市場預測

  • 市場規模的預測
  • 競爭情形的預測
目錄
Product Code: 1506189

Gynecological inflammation is a disease that troubles contemporary women. According to WHO's survery on the health conditions of women all over the world, the incidence of gynecological disease has reached over 65% and over 70% among women of childbearing age. The number of cases of urinary system infections has hit over 300 million around the world, which leads to the rapid expansion of gynecological drug market. The epidemiological study conducted by China also shows that the incidence of reproductive tract infection among urban married women has exceeded 40% in China and that many women suffer from different degrees of urinary system infection in their lifetime.

Nifuratel can effectively kill those bacteria, protozoa and molds that lead to vaginal infections without any acute or chronic side effects. Due to its pleiotropic effects, nifuratel can be used for all kinds of vaginitis caused by bacteria, trichomonas and molds infection. Nifuratel, a variety of broad-spectrum antimicrobial agents with two methods of application: oral and external application, was developed by Doppel Farmaceutici. S. r. l. with the trade name of Macmiror/ Macmiror. In 2001, SFDA approved nifuratel made by Doppel Farmaceutici. S. r. l. to be sold in China with such main species as sugarcoated tablets, vaginal tablets and vaginal suppositories under the trade names of Macmiror and Macmiror Complex. Nifuratel develops fast after entering China with annual sales rising from CNY 53.2 thousand in 2005 to CNY 38.03 million in 2014 and CAGR reaching 24.43% and some Chinese enterprises have also started to make generic drugs.

With the fast development of Chinese economy and the improvement of national health insurance system, many kinds of gynecological inflammation drugs, driven by new concepts of treatment, have become affordable to civilians. In general, the gynecological anti-infective market in sample hospitals is dominated by pharmaceutical preparations which operate quickly. On the other hand, Chinese patent medicine made by local enterprises fail to enter the market, instead, they are widely used in mother and child healthcare hospitals, medical institutions based in communities as well as the rural market.

Readers can get at least the following information through this report:

  • market size of nifuratel in China
  • major manufacturers of nifuratel in the Chinese market and their market share
  • retail price of nifuratel in Chinese market
  • market outlook of nifuratel in China

The author suggests the following groups of people purchase this report:

  • manufacturers of gynecological drugs
  • investors/ research institutions interested in Chinese medicine market
  • any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Nifuratel

  • 1.2. Indication
  • 1.2. Sales Status in Global Market

2. Market Profile of Nifuratel in China, 2010-2015

  • 2.1. Patent and Approval Status of Nifuratel in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Status of Nifuratel in China, 2010-2014

  • 3.1. Sales Value
    • 3.1.1. Overall Sales Value
    • 3.1.2. Sales Value by Regions
  • 3.2. Sales Volume
    • 3.2.1. Overall Sales Volume
    • 3.2.2. Sales Volume by Regions

4. Survey on Market Share of Major Manufacturers of Nifuratel in China, 2010-2014

  • 4.1. Market Share by Sales Value
  • 4.2. Market Share by Sales Volume

5. Survey on Dosage Forms of Nifuratel in China, 2010-2014

  • 5.1. Share of Different Dosage Forms by Sales Value
  • 5.2. Share of Different Dosage Forms by Sales Volume

6. Reference Price of Nifuratel in Chinese Hospitals in 2014

  • 6.1. Monsanto Italy S.p.A. (Trade Name: Macmiror)
  • 6.2. Beijing Laneva Pharmaceutical Co., Ltd (Trade Name: Lang Yi Jun)
  • 6.3. Lifecare (Trade Name: Kuaihe) (Trade Name: Kuaihe)
  • 6.4. Doppel Farmaceutici (Italy) (Trade Name: Macmiror)
  • 6.5. Yantai Luyin Pharmaceutical Co., Ltd (Trade Name: Pu Le)

7. Major Manufacturers of Nifuratel in Chinese Market, 2010-2014

  • 7.1. Lifecare
  • 7.2. Beijing Laneva Pharmaceutical Co., Ltd
  • 7.3. Yantai Luyin Pharmaceutical Co., Ltd
  • 7.4. Doppel Farmaceutici (Italy)
  • 7.5. Monsanto Italy S.p.A.

8. Market Outlook of Nifuratel in China, 2015-2019

  • 8.1. Forecast of Market Size
  • 8.2. Forecast of Competitive Landscape

Table of Selected Contents

  • Chart Patent Status of Nifuratel in China
  • Chart Approval Status of Nifuratel in China
  • Chart Sales Status of Nifuratel in Chinese Market, 2010-2014
  • Chart Sales Value of Nifuratel in China, 2010-2014
  • Chart Sales Value of Nifuratel in Some Regions in China, 2010-2014
  • Chart Sales Volume of Nifuratel in China, 2010-2014
  • Chart Sales Volume of Nifuratel in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Nifuratel for Sales Value, 2010-2014
  • Chart Sales Value and Market Share of Nifuratel Made by Doppel Farmaceutici (Italy) in China, 2010-2014
  • Chart Sales Value and Market Share of Nifuratel Made by Beijing Laneva in China, 2010-2014
  • Chart Sales Value and Market Share of Nifuratel Made by Lifecare in China, 2010-2014
  • Chart Sales Value and Market Share of Nifuratel Made by Monsanto (IT) in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Nifuratel for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Nifuratel Tablets in China, 2010-2014
  • Chart Sales Value and Market Share of Nifuratel Capsules in China, 2010-2014
  • Chart Price of Nifuratel Made by Doppel Farmaceutici (Italy) in Some Chinese Cities in 2014
  • Chart Price of Nifuratel Made by Beijing Laneva Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
  • Chart Price of Nifuratel Made by Lifecare in Some Chinese Cities in 2014
  • Chart Price of Nifuratel Made by Doppel Farmaceutici (Italy) in Some Chinese Cities in 2014
  • Chart Price of Nifuratel Made by Yantai Luyin Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Back to Top